| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |